Live feed06:30:00·694dPRReleasevia QuantisnowBionomics Announces Successful End-of-Phase 2 Meeting with the FDA on the Development of BNC210 in Post-Traumatic Stress DisorderByQuantisnow·Wall Street's wire, on your screen.BNOX· Bionomics LimitedHealth Care
